Q1 2023 Orexo AB Earnings Call Transcript
()-&
Welcome to this first quarter report from Orexo, a quarter, which is a little mixed back, but very much in line from a cost perspective and a financial perspective with our expectations for the quarter. Of course, below the top line numbers, there are both some positive development but also some disappointments. But all in all, I'm quite pleased in the way that we have been managing the expenses and the operations during the quarter. And moving into the first section, our key achievements for the quarter. And I had a headline in the CEO comments calling a navigating troubled water. And it has been a challenging quarter, and we knew that when we ended the quarter, then we had the OX124 filing which we didn't anticipate that we had to withdraw from FDA and prepare a refiling later this year. But when we look at the revenues, we are quite a lot in line with last year. There is some support from currency effects. But I'm also quite pleased to see that our subsalt sales in U.S. dollars is actually slightly
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
